In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
Data boom to data shroom: Mycelium could one day be data storage
In Ohio, scientists at Ohio State University have shown that mushroom mycelium can act as a form of data storage. In controlled lab experiments,...
Wooden compass points dementia patients back home
In the Netherlands, a startup has unveiled a device for dementia patients that is comprised of a single arrow that points to only one...
Snack to the future: Nutri3D wants to 3D print your next sweet treat
In Italy, researchers in the Nutri3D project have unveiled prototypes of nutrient-rich sweet snacks made from cultured plant cells, fruit byproducts, and 3D printing....